Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891–9895”

Published:2023-05-16 Issue:5 Volume:30 Page:5050-5053
ISSN:1718-7729
Container-title:Current Oncology
language:en
Short-container-title:Current Oncology

Author:

Rayson Daniel¹,Gandhi Sonal²,Joy Anil A.³,Brezden-Masley Christine⁴^ORCID,Gelmon Karen A.⁵,Sehdev Sandeep⁶,Cescon David⁷,Chia Stephen⁵

Affiliation:

1. Division of Medical Oncology, Department of Medicine, Queen Elizabeth II Health Sciences Center, Halifax, NS B3H 2Y9, Canada

2. Division of Medical Oncology/Hematology, Odette Cancer Centre Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada

3. Division of Medical Oncology, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada

4. Division of Medical Oncology, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada

5. Division of Medical Oncology, British Columbia Cancer Centre, Vancouver, BC V5Z 4E6, Canada

6. Department of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada

7. Department of Medical Oncology, University Health Network, Toronto, ON M5G 1Z5, Canada

Abstract

We appreciate the opportunity to respond to the comment [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/1718-7729/30/5/381/pdf

Reference9 articles.

1. The CADTH pCODR Expert Review Committee Process Explained. Comment on Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891–9895;Trudeau;Curr. Oncol.,2023

2. Access to neoadjuvant pertuzumab for HER2 positive breast cancer in Canada: A dilemma increasingly difficult to explain;Rayson;Curr. Oncol.,2022

3. (2023, March 15). Available online: cadth.ca/cadth-reimbursement-reviews.

4. (2023, March 15). Available online: https://www.pcpacanada.ca.

5. Houlihan, J. Personal communication.